NSC |
Compound |
Enrichment |
Correlation |
NSC 120925 |
Null |
0.049100146992119 |
0.2523995 |
NSC 132277 |
Ethanesulfonic acid, compd. with 1,6-dihydro-6,6-dimethyl-1-[4-(4-phenylbutyl)phenyl]-1,3,5-triazine-2,4-diamine (1:1) |
0.049100146992119 |
0.21698222 |
NSC 132791 |
Butyric acid, 2-hydroxy-2-methyl-, 4-ester with 1,3a.beta.,4,7,7a.alpha.,11,11a,11b.alpha.-octahydro-1.alpha.,2.alpha.,4.beta.,11.beta.-tetrahydroxy-3.alpha.,8,11a.beta.-trimethyl-2H-1,11c.beta.-(epo |
0.049100146992119 |
0.036611506 |
NSC 133118 |
2H-1,2,3-Triazolo[4,5-d]pyrimidin-7-amine, 2-.beta.-D-ribofuranosyl- (9CI) |
0.049100146992119 |
0.088725702 |
NSC 13484 |
Null |
0.049100146992119 |
0.095533951 |
NSC 135073 |
WITHACNISTIN |
0.049100146992119 |
0.15350281 |
NSC 144163 |
Quinoxaline, 6-chloro-2,3-bis(iodomethyl)- |
0.049100146992119 |
0.12749707 |
NSC 168516 |
Benzene, 1,1'-(1,2-ethanediyl)bis[2,5-dimethoxy- |
0.049100146992119 |
0.60830164 |
NSC 208885 |
Null |
0.049100146992119 |
-0.014219617 |
NSC 21683 |
Null |
0.049100146992119 |
0.60784959 |